Information Provided By: 
Fly News Breaks for November 23, 2015
BCR
Nov 23, 2015 | 08:36 EDT
After C.R. Bard agreed to buy Liberator Medical, JMP Securities says the deal "will bring incremental reimbursement expertise, potentially open the door to other chronic disease states, increase direct contact with patients and... provide a tailwind of about 2% to sales and some EPS accretion." The firm reiterates a $207 price target and Outperform rating on C.R. Bard.
News For BCR From the Last 2 Days
There are no results for your query BCR
